Novacyt investor relations
WebNOVACYT has 8 current employee profiles, including Chief Executive Officer Graham Mullis. Graham Mullis Chief Executive Officer Anthony Dyer Chief Corporate Development Officer Ruth Powell Managing Director of NOVAprep & Lab21 Services Paul Eros Corporate Business Development Director Mandy Cowling Corporate & Investor Relations Manager WebNovacyt SA Graham Mullis, Chief Executive Officer James McCarthy, Chief Financial Officer +44 (0)1276 600081 SP Angel Corporate Finance LLP (Nominated Adviser and Broker) Matthew Johnson / Charlie Bouverat (Corporate Finance) Vadim Alexandre / Rob Rees (Corporate Broking) +44 (0)20 3470 0470 Numis Securities Limited (Joint Broker)
Novacyt investor relations
Did you know?
WebNovacyt is a leading global diagnostics company. We protect people and society in the fight against infectious diseases by developing tests that accurately detect infections, allowing us to help safeguard people and … WebNovacyt, founded in 2006, by an experimented team coming from biotech and industrial companies, is active in developing, manufacturing and marketing advanced and innovative solutions for cytology. Use the CB Insights Platform to explore Novacyt's full profile. ... Who are the investors of Novacyt? Investors of Novacyt include Wilco.
WebNOVACYT : Press releases relating to NOVACYT Investor relations Börse Stuttgart: NYZ Börse Stuttgart WebMay 30, 2024 · See Novacyt funding rounds, investors, investments, exits and more. Evaluate their financials based on Novacyt's post-money valuation and revenue.
WebNovacyt Group (UK) Unit 1, Watchmoor Point, Watchmoor Road, Camberley, Surrey GU15 3AD. T +44 (0) 1276 600081. F +44 (0) 1276 600151. E [email protected]. … WebNOVACYT develops cellular diagnostics with a growing portfolio of cancer and infectious disease products and services. Vélizy-villacoublay, Ile-de-France, France 101-250 Post-IPO Debt Public www.novacyt.com/ 35,439 …
WebContact - Novacyt Get In Touch Please get in touch using the details below. Alternatively, use the direct contact form below. We’re looking forward to hearing from you. Tel: +44 …
WebPlease get in touch using the details below. Alternatively, use the direct contact form below. We’re looking forward to hearing from you Mandy Cowling Corporate & Investor Relations … Advisor and Investor Contacts; AIM Rule 26 information; Corporate Governance; Our … Company York House, School Lane, Chandlers Ford, Eastleigh, SO53 4DG … crypto exchanges xrpWebNovacyt Group. Jan 2024 - Present5 years 2 months. Cambridge & Camberley. The Corporate & Investor Relations Manager is a multi … crypto executive order leakWebMar 22, 2024 · Novacyt SA is engaged in developing and selling diagnostic products for cancer and infectious diseases. Its diagnostic products are used in LBC, oncology, microbiology, hematology, and serology... crypto executive order bidenWebSep 29, 2024 · Appointed CEO of Novacyt in 2024 Over 25 years of global experience in pharmaceuticals & biopharmaceutical companies Internationally experienced, strategic … crypto exchanges with margin tradingWebMar 24, 2024 · Investor Relations Novacyt SA NCYT Ownership Morningstar Rating Rating as of Mar 24, 2024 Quote Chart Stock Analysis News Price vs Fair Value ... crypto exchanges with instant depositWebNovacyt is an innovative high growth diagnostic group of companies founded in 2005 and focused on the design, manufacture and supply of a growing portfolio of oncology and infectious disease diagnostic products. They are passionate about their business and the healthcare industry sector they work with and would like to thank you for your ... crypto executive order summaryWebSolidifying this position, Novacyt was among the first to respond to the COVID-19 pandemic in 2024, providing a rapid and reliable gold standard SARS-CoV-2 test kit that the WHO approved. ... E [email protected]. www.novacyt.com. Registered Address: Novacyt Group (France) 13 Avenue Morane Saulnier 78140. Vélizy-Villacoublay France. crypto exhibition